Evidence-based assessment/Bereavement or Complicated Grief

Click Here for Landing Page

HGAPS New for Fall 2022: HGAPS and Psychology Conferences

Click Here for Landing Page

HGAPS is finding new ways to make psychological science conferences more accessible!

Here are examples from APA 2022 and the JCCAP Future Directions Forum. Coming soon... ABCT!
~ More at HGAPS.org ~

Medical disclaimer: This page is for educational and informational purposes only and may not be construed as medical advice. The information is not intended to replace medical advice offered by physicians. Please refer to the full text of the Wikiversity medical disclaimer.

Overview

Losing a friend or a loved one is an inevitable part of growing up.

Preparation phase

Diagnostic criteria for post traumatic stress disorder

ICD-10 Diagnostic Criteria
(insert ICD-10 diagnostic criteria)

Changes in DSM-5

The diagnostic criteria for post traumatic stress disorder changed slightly from DSM-IV to DSM-5. Summaries are available here and here.

Base rates of adolescent depression in different clinical settings

This section describes the demographic setting of the population(s) sampled, base rates of diagnosis, country/region sampled, and the diagnostic method that was used. Using this information, clinicians will be able to anchor the rate of adolescent depression that they are likely to see in their clinical practice.

To see prevalence rates across multiple disorders, click here.

****make sure to find the specific base rates for your specific disorder from the table in the link above and paste them into the table below

Demography	Setting	Base Rate	Diagnostic Method
All of U.S.A.	Acute psychiatric hospitalizations in 2009-2010 children (under the age of 15) (Blader & Carlson, 2010)	13%	Centers for Disease Control survey of discharge diagnoses

^p:Parent interviewed as component of diagnostic assessment; ^y:youth interviewed as part of diagnostic assessment.

Prediction phase

Psychometric properties of screening instruments for (insert portfolio name)

The following section contains a list of screening and diagnostic instruments for (insert portfolio name). The section includes administration information, psychometric data, and PDFs or links to the screenings.

Screenings are used as part of the prediction phase of assessment; for more information on interpretation of this data, or how screenings fit in to the assessment process, click here.

For a list of more broadly reaching screening instruments, click here.

****Below are two examples of what you should put in this table.

Screening measures for (insert portfolio name)
Measure	Format (Reporter)	Age Range	Administration/ Completion Time	Interrater Reliability	Test-Retest Reliability	Construct Validity	Content Validity	Highly Recommended	Free and Accessible Measures
Children's Depression Inventory *not free	Structured self-report^[1]	7-17	15-20 minutes^[1]	NA	A	G	G	X	Link to purchase CDI
Mood and Feelings Questionnaire (MFQ)	Self-report	6-17	5-10 minutes^[2]	NA	A	G	A	X	Homepage PDF

Note: L = Less than adequate; A = Adequate; G = Good; E = Excellent; U = Unavailable; NA = Not applicable

Likelihood ratios and AUCs of screening measures for (insert portfolio name)

For a list of the likelihood ratios for more broadly reaching screening instruments, click here.

****Here is the the table for psychometric properties. An example is listed below of a good example. Either include link to the PDF (uploaded from OSF) if applicable, or denote that the screener is not free.

Screening Measure (Primary Reference)	AUC (sample size)	DLR+ (score)	DLR- (score)	Clinical Generalizability	Download
Child Behavior Checklist (CBCL) Anxious/Depressed Scale T-score^[3]	.70 (N=470)	3.78 (60+)	.39 (<60)	High. Large diverse sample with mixed depression sample compared to samples without depression.	Not free

Interpreting (insert portfolio name) screening measure scores

For information on interpreting screening measure scores, click here.
Also see the page on likelihood ratios in diagnostic testing for more information

Prescription phase

Gold standard diagnostic interviews

For a list of broad reaching diagnostic interviews sortable by disorder with PDFs (if applicable), click here.

Recommended diagnostic interviews for (insert portfolio name)

****This table should contain diagnostic interviews that are specific just to the disorder your portfolio focuses on. General or broad reaching diagnostic interviews, like the KSADS, are listed in the link in the section above.

Diagnostic instruments for (insert portfolio name)
Measure	Format (Reporter)	Age Range	Administration/ Completion Time	Interrater Reliability	Test-Retest Reliability	Construct Validity	Content Validity	Highly Recommended	Free and Accessible Measures
Children's Depression Rating Scale - Revised (CDRS-R)	Structured Interview^[4]	6-12	15-20 minutes	G	A	G	G	X	Link to purchase CDRS-R PDF (excerpt)

Note: L = Less than adequate; A = Adequate; G = Good; E = Excellent; U = Unavailable; NA = Not applicable

Severity interviews for (insert portfolio name here)

Measure	Format (Reporter)	Age Range	Administration/ Completion Time	Interrater Reliability	Test-Retest Reliability	Construct Validity	Content Validity	Highly Recommended	Free and Accessible Measures
Children's Depression Rating Scale - Revised (CDRS-R)	Structured Interview^[4]	6-12	15-20 minutes	G	A	G	G	X	Link to purchase CDRS-R PDF (excerpt)

Note: L = Less than adequate; A = Adequate; G = Good; E = Excellent; U = Unavailable; NA = Not applicable

Process phase

The following section contains a brief overview of treatment options for (insert portfolio name) and list of process and outcome measures for (insert portfolio name). The section includes benchmarks based on published norms for several outcome and severity measures, as well as information about commonly used process measures. Process and outcome measures are used as part of the process phase of assessment. For more information of differences between process and outcome measures, see the page on the process phase of assessment.

Process measures

****If applicable, insert information on process measures commonly used with your portfolio's disorder.

Outcome and severity measures

This table includes clinically significant benchmarks for (insert portfolio name here) specific outcome measures

Information on how to interpret this table can be found here.
Additionally, these vignettes might be helpful resources for understanding appropriate adaptation of outcome measures in practice.
For clinically significant change benchmarks for the CBCL, YSR, and TRF total, externalizing, internalizing, and attention benchmarks, see here.

Clinically significant change benchmarks with common instruments for (insert portfolio name)
Benchmarks Based on Published Norms
Measure	Subscale	Cut-off scores			Critical Change (unstandardized scores)
Measure	Subscale	A	B	C	95%	90%	SE_difference
Beck Depression Inventory-II		4	22	15	9	8	4.8
CBCL T-scores (2001 Norms)	Total	49	70	58	5	4	2.4

****replace the numbers

Treatment

****Insert brief description of commonly used therapy for your disorder. Insert bullet point below with links replaced to resources that describe therapy more in depth.

Please refer to the page on (insert the link for the wikipedia page on portfolio's disorder) for more information on available treatment for (insert portfolio name) or go to Effective Child Therapy (replace link) for a curated resource on effective treatments for (insert portfolio name).

External resources

ICD-10 diagnostic criteria
Find-a-Therapist (a curated list of find-a-therapist websites where you can find a provider)
NIMH (information about (insert portfolio name))
John's Hopkins Resource (guide-guide about (insert portfolio name), treatment, and more)
OMIM (Online Mendelian Inheritance in Man)
1. 608516
2. 608520
3. 608691
eMedicine entry for adult depression
Effective Child Therapy page for (insert name)
1. Effective Child Therapy is website sponsored by Division 53 of the American Psychological Association (APA), or The Society for Clinical Child and Adolescent Psychology (SCCAP), in collaboration with the Association for Behavioral and Cognitive Therapies (ABCT). Use for information on symptoms and available treatments.

****replace these links and add any extra links to external resources as relevant

References

Click here for references

↑ ^1.0 ^1.1 "Children's Depression Inventory 2™". www.pearsonclinical.com. Retrieved 2018-03-01.
↑ "CEBC » Assessment Tool › Mood And Feelings Questionnaire Mfq". www.cebc4cw.org. Retrieved 2018-03-01.
↑ Achenbach, Thomas M. (1991). Child behavior checklist for ages 4-18 ([11th print.] ed.). Burlington, VT: T.M. Achenbach. ISBN 0938565087.
↑ ^4.0 ^4.1 Mayes, Taryn L.; Bernstein, Ira H.; Haley, Charlotte L.; Kennard, Betsy D.; Emslie, Graham J. (2010-12). "Psychometric Properties of the Children's Depression Rating Scale–Revised in Adolescents". Journal of Child and Adolescent Psychopharmacology 20 (6): 513–516. doi:10.1089/cap.2010.0063. ISSN 1044-5463. PMID 21186970. PMC PMC3003451. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003451/.

[:0-1] 1.0 ^1.1 "Children's Depression Inventory 2™". www.pearsonclinical.com. Retrieved 2018-03-01.

[2] "CEBC » Assessment Tool › Mood And Feelings Questionnaire Mfq". www.cebc4cw.org. Retrieved 2018-03-01.

[Achenbach1991-3] Achenbach, Thomas M. (1991). Child behavior checklist for ages 4-18 ([11th print.] ed.). Burlington, VT: T.M. Achenbach. ISBN 0938565087.

[:4-4] 4.0 ^4.1 Mayes, Taryn L.; Bernstein, Ira H.; Haley, Charlotte L.; Kennard, Betsy D.; Emslie, Graham J. (2010-12). "Psychometric Properties of the Children's Depression Rating Scale–Revised in Adolescents". Journal of Child and Adolescent Psychopharmacology 20 (6): 513–516. doi:10.1089/cap.2010.0063. ISSN 1044-5463. PMID 21186970. PMC PMC3003451. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003451/.

[1]

[2]

[3]

[4]